Spero Therapeutics Aktie
1,60
EUR
-0,04
EUR
-2,56
%
1,89
USD
-0,05
USD
-2,58
%
Werbung
Spero Therapeutics Aktie Analyse
09.02.18 | Spero Therapeutics Overweight | Cantor Fitzgerald | |
27.11.17 | Spero Therapeutics Outperform | Oppenheimer & Co. Inc. | |
27.11.17 | Spero Therapeutics Buy | Stifel, Nicolaus & Co., Inc. |
Werbung
Werbung